• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿激酶受体在人表皮样癌细胞系(HEp3)中的过表达增加了在绒毛尿囊膜上以及在严重联合免疫缺陷小鼠体内的致瘤性。

Over-expression of urokinase receptor in human epidermoid-carcinoma cell line (HEp3) increases tumorigenicity on chorio-allantoic membrane and in severe-combined-immunodeficient mice.

作者信息

Lyu M A, Choi Y K, Park B N, Kim B J, Park I K, Hyun B H, Kook Y H

机构信息

Department of Microbiology and Cancer Research Center, Seoul National University College of Medicine, Republic of Korea.

出版信息

Int J Cancer. 1998 Jul 17;77(2):257-63. doi: 10.1002/(sici)1097-0215(19980717)77:2<257::aid-ijc15>3.0.co;2-8.

DOI:10.1002/(sici)1097-0215(19980717)77:2<257::aid-ijc15>3.0.co;2-8
PMID:9650562
Abstract

Using chorio-allantoic membranes (CAMs) of chick embryos and severe-combined-immunodeficient (SCID) mice, we investigated the effects of urokinase-type plasminogen-activator receptor (u-PAR) over-expression on the process of invasion and tumorigenicity. By the transfection of u-PAR cDNA, 3 u-PAR-over-expressing clones expressing 1.6- to 4.6-fold more u-PAR mRNA than parent cells were obtained from a human epidermoid-carcinoma cell line, HEp3, that expresses urokinase-type plasminogen activator (u-PA) and u-PAR. All the u-PAR-over-expressing clones showed greater invasiveness (13 to 29%) than that of parent HEp3 cells on CAMs. Immunohistochemistry revealed densely stained u-PAR-positive cells near the margin of the tumor, where a u-PAR-over-expressing clone, designated SM-3, was invading thickened fibrous tissue on CAMs. Three u-PAR-overexpressing clones formed larger tumors (>40 mm3) than did parent HEp3 cells on CAMs. Moreover, when the u-PAR-overexpressing clone (SM-3) was injected s.c. into the back of the SCID mice it produced a larger tumor volume than the control (HEp3) and down-regulated (AS-2) clones and significantly shortened the survival of SCID mice. These results demonstrate that increased u-PAR expression is an important factor in determining the malignant phenotype that makes cancer cells more invasive and tumorigenic.

摘要

利用鸡胚的绒毛尿囊膜(CAMs)和严重联合免疫缺陷(SCID)小鼠,我们研究了尿激酶型纤溶酶原激活物受体(u-PAR)过表达对侵袭和致瘤过程的影响。通过转染u-PAR cDNA,从表达尿激酶型纤溶酶原激活物(u-PA)和u-PAR的人表皮样癌细胞系HEp3中获得了3个u-PAR过表达克隆,其u-PAR mRNA表达量比亲本细胞高1.6至4.6倍。所有u-PAR过表达克隆在CAMs上的侵袭性均比亲本HEp3细胞更强(13%至29%)。免疫组织化学显示,在肿瘤边缘附近有密集染色的u-PAR阳性细胞,其中一个u-PAR过表达克隆(命名为SM-3)正在侵袭CAMs上增厚的纤维组织。3个u-PAR过表达克隆在CAMs上形成的肿瘤比亲本HEp3细胞更大(>40 mm3)。此外,当将u-PAR过表达克隆(SM-3)皮下注射到SCID小鼠背部时,它产生的肿瘤体积比对照(HEp3)和下调(AS-2)克隆更大,并显著缩短了SCID小鼠的生存期。这些结果表明,u-PAR表达增加是决定恶性表型的一个重要因素,该表型使癌细胞更具侵袭性和致瘤性。

相似文献

1
Over-expression of urokinase receptor in human epidermoid-carcinoma cell line (HEp3) increases tumorigenicity on chorio-allantoic membrane and in severe-combined-immunodeficient mice.尿激酶受体在人表皮样癌细胞系(HEp3)中的过表达增加了在绒毛尿囊膜上以及在严重联合免疫缺陷小鼠体内的致瘤性。
Int J Cancer. 1998 Jul 17;77(2):257-63. doi: 10.1002/(sici)1097-0215(19980717)77:2<257::aid-ijc15>3.0.co;2-8.
2
The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy.尿激酶受体的反义抑制对人鳞状细胞癌恶性程度的影响。
EMBO J. 1994 Sep 1;13(17):3983-91. doi: 10.1002/j.1460-2075.1994.tb06714.x.
3
Co-expression of urokinase-type plasminogen activator and its receptor in human gastric-cancer cell lines correlates with their invasiveness and tumorigenicity.尿激酶型纤溶酶原激活剂及其受体在人胃癌细胞系中的共表达与其侵袭性和致瘤性相关。
Int J Cancer. 1997 May 29;71(5):867-73. doi: 10.1002/(sici)1097-0215(19970529)71:5<867::aid-ijc27>3.0.co;2-3.
4
Reduction in surface urokinase receptor forces malignant cells into a protracted state of dormancy.表面尿激酶受体的减少迫使恶性细胞进入长期休眠状态。
J Cell Biol. 1997 May 5;137(3):767-77. doi: 10.1083/jcb.137.3.767.
5
Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas.尿激酶型纤溶酶原激活剂、1型纤溶酶原激活剂抑制剂、尿激酶受体及α₂-巨球蛋白受体在人乳腺癌中的免疫组织化学定位
Int J Cancer. 1996 May 16;66(4):441-52. doi: 10.1002/(SICI)1097-0215(19960516)66:4<441::AID-IJC6>3.0.CO;2-W.
6
Cellular distribution and clinical value of urokinase-type plasminogen activator, its receptor, and plasminogen activator inhibitor-2 in esophageal squamous cell carcinoma.尿激酶型纤溶酶原激活物及其受体和纤溶酶原激活物抑制剂-2在食管鳞状细胞癌中的细胞分布及临床价值
Am J Pathol. 2000 Feb;156(2):567-75. doi: 10.1016/S0002-9440(10)64761-X.
7
Urokinase (u-PA) and the u-PA receptor. Modulation of in vitro invasiveness of human bladder cancer cell lines.尿激酶(u-PA)与尿激酶受体。对人膀胱癌细胞系体外侵袭性的调节
Adv Exp Med Biol. 1999;462:399-412.
8
Up-regulation of urokinase and urokinase receptor genes in malignant astrocytoma.恶性星形细胞瘤中尿激酶及尿激酶受体基因的上调
Am J Pathol. 1995 May;146(5):1150-60.
9
Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens.尿激酶系统在胃癌中的表达:独立患者系列中的预后影响以及术前活检和肠化生标本中预测价值的首个证据。
Cancer. 2006 Mar 1;106(5):1026-35. doi: 10.1002/cncr.21682.
10
Loss of the metastatic phenotype by a human epidermoid carcinoma cell line, HEp-3, is accompanied by increased expression of tissue inhibitor of metalloproteinase 2.人表皮样癌细胞系HEp-3转移表型的丧失伴随着金属蛋白酶组织抑制剂2表达的增加。
Cancer Res. 1992 Oct 15;52(20):5597-603.

引用本文的文献

1
The Chorioallantoic Membrane Xenograft Assay as a Reliable Model for Investigating the Biology of Breast Cancer.绒毛膜尿囊膜异种移植试验作为研究乳腺癌生物学特性的可靠模型
Cancers (Basel). 2023 Mar 10;15(6):1704. doi: 10.3390/cancers15061704.
2
A Face-To-Face Comparison of Tumor Chicken Chorioallantoic Membrane (TCAM) In Ovo with Murine Models for Early Evaluation of Cancer Therapy and Early Drug Toxicity.肿瘤鸡胚绒毛尿囊膜(TCAM)卵内模型与小鼠模型用于癌症治疗早期评估和早期药物毒性的面对面比较
Cancers (Basel). 2022 Jul 21;14(14):3548. doi: 10.3390/cancers14143548.
3
Chick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis.
鸡胚绒毛尿囊膜(CAM)试验作为一种体内模型,用于研究新鉴定分子对卵巢癌侵袭和转移的影响。
Int J Mol Sci. 2012;13(8):9959-9970. doi: 10.3390/ijms13089959. Epub 2012 Aug 10.
4
Synthesis, biological evaluation, and structure-activity relationships of novel substituted N-phenyl ureidobenzenesulfonate derivatives blocking cell cycle progression in S-phase and inducing DNA double-strand breaks.新型取代 N-苯基脲基苯磺酸盐衍生物的合成、生物评价及构效关系研究,这些衍生物能阻断 S 期细胞周期进程并诱导 DNA 双链断裂。
J Med Chem. 2012 Jul 12;55(13):6194-208. doi: 10.1021/jm3006492. Epub 2012 Jun 21.
5
Design, synthesis, biological evaluation, and structure-activity relationships of substituted phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonates as new tubulin inhibitors mimicking combretastatin A-4.设计、合成、生物评价及取代苯基 4-(2-氧代咪唑烷-1-基)苯磺酸盐作为新型微管蛋白抑制剂的构效关系研究,该抑制剂模拟了 combretastatin A-4。
J Med Chem. 2011 Jul 14;54(13):4559-80. doi: 10.1021/jm200488a. Epub 2011 Jun 13.
6
Challenges for drug discovery - a case study of urokinase receptor inhibition.药物研发面临的挑战——以尿激酶受体抑制为例的案例研究
Comb Chem High Throughput Screen. 2009 Dec;12(10):961-7. doi: 10.2174/138620709789824727.
7
Quantitative determination of tumor cell intravasation in a real-time polymerase chain reaction-based assay.基于实时聚合酶链反应的检测中肿瘤细胞内渗的定量测定。
Clin Exp Metastasis. 2002;19(4):313-8. doi: 10.1023/a:1015563031769.